Business / Finance

RSS

Zalicus third quarter revenue increases to $2.4 million

Zalicus Inc. today reported financial results for the third quarter ended September 30, 2011.

2 Nov 2011

Teva third quarter net sales increase 2% to $4.34 billion

Teva Pharmaceutical Industries Ltd. today reported results for the quarter ended September 30, 2011.

2 Nov 2011

SurModics to sell Pharma assets to Evonik for $30 million

SurModics, Inc., a leading provider of surface modification technologies to the healthcare industry, announced today that it has entered into a definitive agreement to sell its SurModics Pharmaceuticals assets to Evonik Industries AG for $30 million in cash.

2 Nov 2011

MEDNAX acquires Bexar Pediatric Surgery in San Antonio

MEDNAX, Inc., today announced the acquisition of a pediatric surgery physician group practice based in San Antonio, TX.

1 Nov 2011

MEDNAX third quarter net income increases 15.7% to $58.2 million

MEDNAX, Inc., the national medical group specializing in neonatal, maternal-fetal, pediatric cardiology, other pediatric subspecialties and anesthesia physician services, today reported earnings per share of $1.19 for the three months ended September 30, 2011.

1 Nov 2011

Rigel reports net loss of $17.9 million for third quarter 2011

Rigel Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2011.

1 Nov 2011

Watson third quarter net income increases 31% to $138.7 million

Watson Pharmaceuticals, Inc. today reported net revenue of $1.1 billion for the third quarter ended September 30, 2011, an increase of 23 percent when compared to $882.4 million in the third quarter 2010. On a non-GAAP basis, net income for the third quarter 2011 increased 31 percent to $138.7 million or $1.09 per diluted share, compared to $105.9 million or $0.85 per diluted share in the third quarter 2010.

1 Nov 2011

Henry Schein third quarter net sales increase 11.5% to $2.1 billion

Henry Schein, Inc., the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 24, 2011.

1 Nov 2011

Akorn third quarter consolidated revenue increases 69% to $36.7M

Akorn, Inc., a niche specialty pharmaceutical company, today reported financial results for the third quarter of 2011.

1 Nov 2011

RTI reports net income of $2.1 million for third quarter 2011

RTI International Metals, Inc., released results today for the third quarter of 2011.

1 Nov 2011

Omega reports operating revenues of $72.8M for third quarter 2011

Omega Healthcare Investors, Inc. today announced its results of operations for the three- and nine-month period ended September 30, 2011.

1 Nov 2011

Global Health Partner third quarter revenues increase 19% to SEK 129.1M

Global Health Partner: THIRD QUARTER 2011. Revenues increased by 19 percent to SEK 129.1 million.

1 Nov 2011

Psyche Systems and Aperio partner to provide integrated LIS and Digital Pathology solution

Psyche Systems Corporation and Aperio announced today that the companies have formed a strategic relationship which will provide customers an end-to-end integrated LIS and Digital Pathology solution.

31 Oct 2011

Insurers look for opportunities for expansion

Big players such as Aetna and Cigna are snapping up smaller companies in an effort to keep earnings figures up.

31 Oct 2011

Initiation of two IPI-145 Phase 1 clinical trials triggers $4M milestone payment to Intellikine

Intellikine, Inc., a company focused on the discovery and development of innovative, small molecule drugs targeting the PI3K/mTOR pathway, announced today that it has earned $4 million in milestone payments upon the initiation of two Phase 1 clinical trials of IPI-145.

31 Oct 2011

Haemonetics second quarter net revenues increase 8% to $179.4 million

Haemonetics Corporation today reported second quarter 2012 GAAP net revenues of $179.4 million, up 8%, net income of $13.9 million, down 35%, and earnings per share of $0.54, down 36%. Excluding transformation costs and contingent consideration income, adjusted second quarter net income was $18.7 million, down 7%, and adjusted earnings per share was $0.72, down 9%. Excluding currency impacts, net revenue was up 6% in the quarter.

31 Oct 2011

Auxilium reports net revenues of $66.7 million for third quarter 2011

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended September 30, 2011.

31 Oct 2011

Pacira's third quarter total revenues decrease to $4.0 million

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the third quarter ended September 30, 2011 and provided an update on the U.S. Food and Drug Administration's (FDA) approval of EXPAREL and the commercial strategy to support the product launch.

31 Oct 2011

Humana third quarter consolidated revenues increase 11% to $9.30 billion

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2011 (3Q11) of $2.67, compared to $2.32 per share for the quarter ended September 30, 2010.

31 Oct 2011

Eye Shelter, Menicon sign SOLO-care contact lens marketing agreement

Menicon Holdings BV and Eye Shelter SA, a wholly owned subsidiary of Laboratoires Thea, a France-based independent ophthalmic group, announced on October 31 that Menicon is to become Eye Shelter's exclusive partner to market the SOLO-care (R) contact lens solutions range in member states of the European Economic Area and Canada.

31 Oct 2011